PMC6351588_01
Kaplan-Mayer estimates showing time from first IRE treatment to first local recurrence for patients with HCC (Hepatocellular carcinoma) and CRLM (Colorectal liver metastases). IRE (Irreversible electroporation).
gr2.jpg
PMC6351588_01_gr2.jpg
fig0010
Graphs of a first recurrence after IRE treatment in patients with HCC and CRCLM are shown in Fig. 2.
Kaplan-Mayer estimates showing time from first IRE treatment until the patient is no longer candidate for curative intended treatment. IRE (Irreversible electroporation). HCC (Hepatocellular carcinoma). CRMLM (colorectal liver metastases).
gr3.jpg
PMC6351588_01_gr3.jpg
fig0015
Time to loss of control is presented in Fig. 3.
Kaplan-Mayer estimates showing overall survival after first IRE treatment for patients with HCC (Hepatocellular carcinoma) and CRCLM (colorectal liver metastases). IRE (Irreversible electroporation).
gr4.jpg
PMC6351588_01_gr4.jpg
fig0020